{"links":{"self":"https://petition.parliament.uk/petitions.json?q=Cancer+&state=closed","first":"https://petition.parliament.uk/petitions.json?q=Cancer+&state=closed","last":"https://petition.parliament.uk/petitions.json?page=3&q=Cancer+&state=closed","next":"https://petition.parliament.uk/petitions.json?page=2&q=Cancer+&state=closed","prev":null},"data":[{"type":"petition","id":738881,"links":{"self":"https://petition.parliament.uk/petitions/738881.json"},"attributes":{"action":"Invest in brain cancer and give rights – turn terminal into treatable","background":"Brain cancer is the biggest cancer killer of children and adults under 40, 87% with a high-grade brain tumour diagnosis die within 5 yrs, and yet it gets just 1% of the national spend on cancer.","additional_details":"We call on the government to increase research funding and legally enshrine the right to try: genome sequencing, trials, immunotherapy, repurposed drugs and vaccines.\r\n1. Increase brain cancer funding to speed up discoveries and trials.\r\n2. Funding so every patient can access whole genome sequencing with personalised treatment.\r\n3. Enshrine the Right to Try innovative treatments.\r\n\r\nTreatments haven’t changed in decades. Increase funding and give patients a fighting chance.","committee_note":"","state":"closed","signature_count":109063,"created_at":"2025-08-23T10:25:22.364Z","updated_at":"2026-06-16T13:30:02.206Z","rejected_at":null,"opened_at":"2025-09-08T12:10:38.559Z","closed_at":"2026-03-08T23:59:59.999Z","moderation_threshold_reached_at":"2025-08-23T16:25:30.000Z","response_threshold_reached_at":"2025-09-09T20:39:00.000Z","government_response_at":"2025-10-03T10:55:37.025Z","debate_threshold_reached_at":"2026-02-26T22:45:50.000Z","debate_scheduled_on":"2026-05-21","scheduled_debate_date":"2026-06-15","debate_outcome_at":"2026-06-16T13:29:59.575Z","creator_name":null,"rejection":null,"government_response":{"responded_on":"2025-10-03","summary":"Every brain cancer diagnosis has life-changing impact on patients and their families. Research is vital to ensure people can get the most effective cutting-edge treatments and highest quality care.","details":"Between 2018/19 and 2023/24, the Department of Health and Social Care, via the National Institute for Health and Care Research (NIHR) directly invested £11.8 million in research projects and programmes focused on brain tumours. NIHR’s wider investments in research infrastructure are estimated to be £37.5 million, supporting the delivery of 261 brain tumour research studies and enabling over 11,400 people to participate in potentially life-changing brain tumour research.\n\nHowever, we understand that more needs to be done to boost research into brain tumours. That is why we are working closely with the patient and researcher communities to stimulate high-quality research applications through:\n\n(i) establishing a national Brain Tumour Research Consortium to bring together researchers from different disciplines to drive scientific advancements in how to prevent, detect, manage and treat brain tumours\n\n(ii) a dedicated funding call for research into wraparound care and rehabilitation for people living with brain tumours\n\n(iii) a partnership with the Tessa Jowell Brain Cancer Mission to fund the next generation of researchers through the Allied Health Professionals Brain Tumour Research Fellowship programme.\n\nIn terms of access to Whole Genome Sequencing (WGS), in November 2020, the NHS became the first national health system in the world to offer WGS as part of routine care. All paediatric, teenage and adult patients with central nervous system/brain tumours are eligible for WGS as represented in the National Genomic Test Directory, which provides guidance on which patients may benefit from genomic testing, alongside the genomic targets to be tested and appropriate technology that should be used.\n\nGenomic testing in the NHS in England is provided through the NHS Genomic Medicine Service (NHS GMS). As outlined in the 10 Year Health Plan, the NHS GMS will work with industry, academia and other partners to generate evidence and models of adoption for genomic innovations in specific priority areas, such as cancer. This will inform commissioning decisions, accelerate adoption and ensure equity of access to genomic testing across England. Additionally, the NHS GMS will roll out a Unified Genomic Record to integrate patient genomic data with relevant clinical and diagnostic data, shorten genomic testing turnaround times, and work with industry to align testing with clinical trials targets and precision medicine access.\n\nRegarding new and personalised treatments, the government is committed to securing patient access to effective and innovative new medicines, including for brain tumours. There are established routes to support timely access for NHS patients to safe and clinically- and cost-effective new medicines and there are no plans to introduce a new Right to Try initiative for new treatments. The National Institute for Health and Care Excellence (NICE) evaluates all new medicines and makes recommendations for the NHS on whether they should be routinely funded by the NHS. NICE aims wherever possible to issue guidance on new medicines close to the point of licensing and our Life Sciences Sector Plan published in July sets out the measures we are taking to streamline decision making to accelerate patient access to new medicines by three to six months. The NHS in England is required to fund medicines recommended by NICE, and NHS England funds cancer medicines from the point of positive draft NICE guidance, accelerating patient access by around five months on average.\n\nAdditionally, the Medicines and Healthcare products Regulatory Agency (MHRA) Early Access to Medicines Scheme (EAMS) is one of the UK’s offerings of Early Access Programmes, where companies have a framework for providing promising treatments in development as unlicensed medicines to patients. The EAMS is designed to give patients with life-threatening or seriously debilitating conditions access to medicinal products that may be used for preventing, diagnosing or treating those conditions, but which are either not yet authorised or not authorised for that use. If there is a medicine in development that incorporates certain diagnostic techniques, they may be eligible for the scheme.\n\nIn terms of future publications, the National Cancer Plan, due to be published later this year, will have patients at its heart and will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and aftercare. It will seek to improve every aspect of cancer care, to improve the experience and outcomes for people with cancer. Our goal is to reduce the number of lives lost to cancer over the next ten years, including for brain cancer.\n\nDepartment of Health and Social Care","created_at":"2025-10-03T10:55:37.022Z","updated_at":"2025-10-03T10:55:37.022Z"},"debate":{"debated_on":"2026-06-15","transcript_url":"https://hansard.parliament.uk/commons/2026-06-15/debates/EDB04B04-7B7A-428F-A73C-74AC24F23ADD/BrainCancer","video_url":"https://www.youtube.com/watch?v=XSYeMnixS1E","debate_pack_url":"https://commonslibrary.parliament.uk/research-briefings/cbp-10486/","public_engagement_url":"","debate_summary_url":"","overview":""},"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":742179,"links":{"self":"https://petition.parliament.uk/petitions/742179.json"},"attributes":{"action":"Lower the age for invites to regular mammograms to 40 & perform annually","background":"Lower the age for when you are first called to 40 and provide funding to carry out Mammograms Annually instead of every Three Years","additional_details":"Early detection is key and the prevalence of Breast Cancer in young patients is rising\r\nI am a Chemotherapy Nurse and working in this Clinical Setting for 8 Years and I have seen a rise in Breast Cancer in Patients under the Age of 40 increase.\r\nEarly detection is key in identifying those Aggressive forms of Breast Cancer\r\n","committee_note":"","state":"closed","signature_count":106212,"created_at":"2025-09-20T08:21:09.508Z","updated_at":"2026-05-21T13:33:13.862Z","rejected_at":null,"opened_at":"2025-10-09T09:53:10.035Z","closed_at":"2026-04-09T22:59:59.999Z","moderation_threshold_reached_at":"2025-09-20T08:41:10.000Z","response_threshold_reached_at":"2025-11-05T09:30:20.000Z","government_response_at":"2025-11-21T11:29:44.277Z","debate_threshold_reached_at":"2026-02-24T21:09:30.000Z","debate_scheduled_on":"2026-05-21","scheduled_debate_date":"2026-06-29","debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":{"responded_on":"2025-11-21","summary":"In line with independent advice from the UK National Screening Committee, the Government does not intend to lower the age or increase the frequency of breast screens.","details":"The Government is guided by the independent scientific advice of the UK National Screening Committee (UK NSC), and it is only where the offer to screen provides more good than harm that a screening programme is recommended. The UK NSC makes its recommendations based on internationally recognised criteria and a rigorous evidence review and consultation process.\n\nAs screening programmes can also cause harms, each of the adult screening programmes has both an upper and lower age range, within which there is good scientific evidence that the benefits of screening outweigh the harms.\n\nWomen younger than the age of 50 are not routinely screened for breast cancer due to the lower risk of women under this age developing breast cancer, and the fact that women below 50 tend to have denser breasts. The denseness of breast tissue reduces the ability of getting an accurate mammogram, the accepted screening test for breast cancer.\n\nDue to this and other factors, there is a risk of over treatment and distress for women who do not have breast cancer but would be subjected to invasive and painful medical treatments and diagnostic tests.\n\nThe 2012 UK independent review of breast cancer screening (the Marmot review) estimated that inviting women aged 50-70 reduces mortality from breast cancer in the population invited by 20% and saves an estimated 1,300 lives a year. The Marmot review found that screening women outside the ages of 50-70 could lead to over-diagnosis (referring women for unnecessary tests) and over-treatment (operating on women with disease which is unlikely to cause serious harm to them).\n\nWe are in line with most European countries, most of whom screen women between the ages of 50-69.\n\nWomen with a very high risk of breast cancer (for example, due to family history) may be offered screening earlier and more frequently, sometimes using MRI rather than a mammogram.\n\nThe UK NSC keeps these age brackets under review. The Committee recognises that screening programmes are not static and that, over time, they may need to change to be more effective.\n\nThe UK National Screening Committee (UK NSC) reviewed the evidence relating to the provision of additional breast screening for women who have dense breast tissue in the summer of 2025 and invited stakeholders’ feedback on the findings to inform future work. In addition, the AgeX – age extension – breast screening research trial has been looking at the effectiveness of offering some women an extra screen between the ages of 47 and 49, and between the ages of 71 and 73. When the results are available, the report will be reviewed by the UK NSC.\n\nDepartment of Health and Social Care","created_at":"2025-11-21T11:29:44.275Z","updated_at":"2025-11-21T11:29:44.275Z"},"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":728751,"links":{"self":"https://petition.parliament.uk/petitions/728751.json"},"attributes":{"action":"Review and fund improved detection and diagnosis of prostate cancer","background":"Require PSA blood tests to be proactively offered to men at highest risk of prostate cancer. Review emerging evidence from the TRANSFORM trial to inform a future national screening programme for prostate cancer. We believe this will make the health system fairer and reduce inequality.","additional_details":"Black men, men with a family history of prostate cancer, and men from socio-economically deprived areas are disproportionately impacted by prostate cancer. We believe that detecting and diagnosing prostate cancer is now safer and more accurate than ever. Prostate Cancer UK’s research suggests that harms of diagnosing prostate cancer have reduced by 79%. Yet it remains the second biggest cancer killer in men in the UK. We think it is time to review NHS guidelines on the PSA blood test and invest in an early detection programme.","committee_note":"","state":"closed","signature_count":14374,"created_at":"2025-05-28T06:36:51.489Z","updated_at":"2026-02-17T16:23:36.635Z","rejected_at":null,"opened_at":"2025-06-24T12:37:37.057Z","closed_at":"2025-12-24T23:59:59.999Z","moderation_threshold_reached_at":"2025-05-28T07:44:10.000Z","response_threshold_reached_at":"2025-08-23T12:37:40.000Z","government_response_at":"2025-09-12T15:09:21.780Z","debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":{"responded_on":"2025-09-12","summary":"The Government has no current plans to require PSA blood tests to be proactively offered to men at highest risk of prostate cancer, because the evidence does not support this.","details":"The Department of Health and Social Care is committed to providing the best care possible for men and we are taking the risks and impact of prostate cancer seriously. We are guided by the independent scientific advice of the UK National Screening Committee (UK NSC), and it is only where the offer to screen provides more good than harm that a screening programme is recommended. The UK NSC makes its recommendations based on internationally recognised criteria and a rigorous evidence review and consultation process. It last reviewed the evidence for screening all men for prostate cancer in 2020 and concluded that the UK should not do so.\n\nWhilst it is recognised that the Prostate Specific Antigen (PSA) test can be a valuable diagnostic tool in certain contexts, such as for men who present with symptoms, its limitations mean that it is not currently recommended for population-level screening, i.e. screening men with no symptoms.\n\nThis is because elevated PSA levels can be caused by non-cancerous conditions such as benign prostatic hyperplasia (BPH), prostatitis, or recent physical activity. This results in high rates of false-positive results, leading to unnecessary anxiety, invasive biopsies, and potential overtreatment. For example, a diagnosis via a biopsy and treatment (prostatectomy and radiotherapy) carries risks of life-changing harm, such as urinary and faecal incontinence, sexual dysfunction, as well as a smaller but serious risk of sepsis. Additionally, some prostate cancers may not produce elevated PSA levels, leading to false-negative results that provide deceptive reassurance. For these reasons, the UK NSC currently considers that these potential risks outweigh the benefits of population screening.\n\nAs part of its commitment to keep its recommendations under review, the UK NSC has commissioned a new evidence review for prostate cancer screening. This covers modelling of the clinical effectiveness and cost of several approaches to prostate cancer screening. It includes different potential ways of screening the whole population, and targeted screening aimed at groups of people identified as being at higher-than-average risk, such as black men or men with a family history of cancer.\n\nThe modelling and evidence reports are now complete, and are being considered by the UK NSC and experts. Subject to no further revisions being required, the UK NSC plans to hold a public consultation towards the end of 2025. After this the UK NSC will make a recommendation. Ministers will then be asked to consider whether to accept the recommendation.\n\nIn the meantime, however, recognising the importance of developing a better test, the Government have invested £16 million in working with Prostate Cancer UK (PCUK) to launch their £42 million TRANSFORM trial, a nationwide study that will compare the most promising tests to look for prostate cancer. It will be the biggest trial in prostate cancer screening for 20 years. It has been developed in consultation, and with the backing of, the NHS, the National Institute for Health and Care Research (NIHR) and the Government. It will ensure that 1 in 10 of the participants invited to take part in the trial is a black man, in acknowledgment of the higher risk black men have of being diagnosed with prostate cancer.  \nThe UK NSC are engaged and working closely with TRANSFORM researchers and stand ready to receive findings as they become available. PCUK anticipate initial findings will be available in three years.\n\nThe Government agree that too many men are dying from prostate cancer. Any death from cancer is a tragedy, which is why this Government will publish a National Cancer Plan later this year. The Plan will have patients at its heart, with the goal to reduce the number of lives lost to cancer. The Government have been listening to and co-designing the Plan with members of the public, the health workforce, charities, academics and other partners. The Call for Evidence received over 11,000 responses. Officials at the Department of Health and Social Care are analysing those responses, to make sure every voice has been heard, to inform our Plan to improve cancer care.\n\nDepartment of Health and Social Care","created_at":"2025-09-12T15:09:21.777Z","updated_at":"2025-09-12T15:09:21.777Z"},"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":725909,"links":{"self":"https://petition.parliament.uk/petitions/725909.json"},"attributes":{"action":"Lower bowel cancer screening age to 30 & funding for investigation of symptoms","background":"We call on the Government to lower the bowel cancer screening age to 30, and provide funding to ensure all patients with symptoms of bowel cancer are fully and quickly investigated, regardless of age, to help prevent further loss of life due to delayed diagnosis.","additional_details":"Bowel cancer is increasing in younger adults and we don't think the current approach reflects this. Early action could save lives.","committee_note":"","state":"closed","signature_count":12286,"created_at":"2025-04-24T08:55:28.959Z","updated_at":"2026-02-17T16:23:36.664Z","rejected_at":null,"opened_at":"2025-06-02T08:15:32.873Z","closed_at":"2025-12-02T23:59:59.999Z","moderation_threshold_reached_at":"2025-04-25T08:34:50.000Z","response_threshold_reached_at":"2025-07-25T06:59:50.000Z","government_response_at":"2025-08-01T15:50:00.244Z","debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":{"responded_on":"2025-08-01","summary":"The Government has no plans to lower the bowel cancer screening age to 30. There is a lack of evidence that the benefits of doing so would outweigh the harms.","details":"The Government has no plans to lower the bowel cancer screening age to 30.\n\nIn the UK, new screening programmes and modifications to existing screening programmes are recommended by the UK National Screening Committee (UK NSC). The UK NSC is an independent scientific advisory committee which advises ministers and the NHS in all four UK nations on all aspects of population and targeted screening and supports implementation.\n\nIt is only where the offer to screen provides more good than harm that a screening programme is recommended. As screening programmes can also cause harms, each of the adult screening programmes has both an upper and lower age range, within which there is good scientific evidence that the benefits of screening outweigh the harms.\n\nThe UK NSC considers all the latest scientific evidence when reviewing the case for screening for different conditions. As the policy is based on the benefits and harms to whole populations, the screening decisions are based on the effect on the whole population, rather than individual circumstances. Where there is a lack of evidence, the UK NSC cannot be confident that screening would benefit the population as a whole. In these circumstances, the proportionate approach is to screen within the range that has evidence to back the policy.\n\nThe NHS bowel screening programme in England was recently extended from 60 to 74 years old to 50 to 74 years old, aligning with the evidence of where the screening programme can do the most good with the least harm caused.\n\nCurrently the evidence does not support lowering the age of bowel screening below 50. However, the UK NSC keeps these age brackets under review, and welcomes any new evidence which suggests the case for a new or modified screening programme via its annual call: https://www.gov.uk/government/publications/uk-nsc-annual-call-submitting-a-screening-proposal/uk-nsc-annual-call-how-to-submit-a-proposal\n\nA more sensitive threshold for the bowel screening faecal immunochemical test (FIT) of 80ug/gm, down from 120ug/gm, is being piloted, and if rolled out nationally could find 700 more colorectal cancers per year and 2,000 high risk polyps.\n\nWith regard to additional funding for investigation of symptoms of bowel cancer, we will get the NHS diagnosing cancer earlier and treating it faster so more patients survive, including those with bowel cancer. As the first step to ensure faster diagnosis and treatment, the NHS is delivering an extra 40,000 operations, scans, and appointments each week.\n\nWe are committed to transforming diagnostic services and will support the NHS to increase diagnostic capacity to meet the demand for diagnostic services through investment.\n\nNational Institute for Health and Care Excellence (NICE) NG12 guidance recommends all patients with colorectal symptoms over the age of 18 (except those with an anal or rectal mass who should be referred urgently) should be offered a FIT10 test to identify those who are at high risk of colorectal cancer who should be referred on to a lower gastrointestinal (lower GI) Urgent Suspected Cancer (USC) pathway. Data from May 2025 shows that 78% of Lower GI USC referrals now have a FIT attached, demonstrating that the test is being used to identify all adults who would benefit from further investigation.\n\nThis intelligent use of FIT as a risk stratification tool in the cancer pathways has led to a significant national reduction in the number of Lower GI USC referrals, as now only those at risk of cancer are being referred. This policy change has not negatively impacted the number of cancers diagnosed and has created endoscopy capacity to extend the NHS Bowel Cancer Screening programme to those aged 50, down from 60.\n\nIn gastroenterology, we will develop an integrated pathway across primary, community and secondary care for common gastroenterology conditions. We will also drive the rapid adoption of remote monitoring in appropriate gastroenterology pathways, which reduces consultant-led outpatient appointments by over 50%. This will benefit patients being checked for gastroenterological conditions, including bowel cancer.\n\nThe NHS is delivering on steps to reduce waiting times for GI endoscopy services, including colonoscopy procedures. This includes the establishment of a national transformation project to recover GI endoscopy services, investment in an additional 80 dedicated endoscopy rooms to expand capacity, as well as a number of Community Diagnostic Centres offering endoscopy services.\n\nOur reforms to cancer care will see more than 100,000 people, including those with bowel cancer, getting diagnosed faster, and thousands more starting treatment within 2 months. We have already hit our target of delivering 2 million extra operations, scans, and appointments 7 months early.\n\nThrough the National Cancer Plan and ongoing reforms to cancer pathways, we remain focused on accelerating diagnosis, boosting survival rates, and reducing inequalities in outcomes for people affected by bowel cancer.\n\nDepartment of Health and Social Care","created_at":"2025-08-01T15:50:00.241Z","updated_at":"2025-08-01T15:50:00.241Z"},"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":743337,"links":{"self":"https://petition.parliament.uk/petitions/743337.json"},"attributes":{"action":" Fund free dental care for head & neck cancer patients  ","background":"We want the Government to fund free dental care for head and neck cancer patients both during and after treatment to address the significant oral health challenges that survivors may face, and to improve their overall quality of life.","additional_details":"Head and neck cancer treatments, such as surgery, radiation and chemotherapy, can result in long-term oral health issues, including dry mouth, tooth decay and infections. These conditions can severely affect survivors' quality of life, their self-esteem and ability to eat, speak. Providing free dental care could ensure patients have access to essential treatments, improve their health outcomes, and reduce the financial burden, similar to other cancer types already covered by healthcare services.","committee_note":"","state":"closed","signature_count":11694,"created_at":"2025-09-26T10:06:31.621Z","updated_at":"2026-05-01T09:06:20.000Z","rejected_at":null,"opened_at":"2025-10-30T10:02:43.012Z","closed_at":"2026-04-30T22:59:59.999Z","moderation_threshold_reached_at":"2025-09-28T10:12:20.000Z","response_threshold_reached_at":"2026-02-12T09:42:40.000Z","government_response_at":"2026-03-05T11:08:00.998Z","debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":{"responded_on":"2026-03-05","summary":"We understand the importance of oral care for cancer patients. There are no current plans to extend free care to cancer patients, although those struggling with NHS dental costs can apply for help.","details":"The Government recognises that patients with cancer, especially those with diagnoses of head or neck cancer, may be more vulnerable to oral health problems during and following their treatment. We are working across the system to ensure that patients who have a diagnosis of cancer receive timely, safe, and effective dental care.\n\nIntegrated care boards (ICBs) are responsible for commissioning primary care services, including NHS dentistry, to meet the needs of local populations and to determine the priorities for investment. NHS England has published guidance for ICBs to help ensure patients with a diagnosis of cancer can access oral healthcare in a timely manner. This guidance is available at the following link: https://www.england.nhs.uk/long-read/oral-healthcare-provision-for-cancer-pathways/. The guidance outlines an “oral health in cancer pathway” for patients with a diagnosis of head and neck cancer, patients awaiting chemotherapy or immunotherapy for any cancer type, and patients that will undergo bone marrow transplantation. This pathway could include oral health assessments, prevention, rehabilitation, and reconstruction in primary (NHS or independent), community, secondary, or tertiary care settings. This would be provided as part of a multi-disciplinary team care plan. Ongoing oral health management for the duration of the cancer therapy would take place.\n\nWhilst there are currently no plans to extend free dental care to those with a diagnosis of head or neck cancer, for those who are struggling with NHS dental charges, there is a range of help available. This includes full exemptions from dental charges and, for those not eligible for exemption, support through the NHS Low Income Scheme.\n\nExemptions are currently available for those who meet the following criteria:\n• people aged under 18, or under 19 and in full-time education\n• people who are pregnant or have had a baby in the last 12 months\n• people who have had a stillbirth in the past 12 months\n• people receiving treatment in an NHS hospital from a hospital dentist (although these patients may still need to pay for dentures or bridges)\n• people receiving War Pension Scheme payments, or Armed Forces Compensation Scheme payments, and for whom the treatment is for their accepted disability\n• people in receipt of certain benefits\n\nFor those who are not eligible for a full exemption, either full or partial support with the costs of NHS dental treatment is available through the NHS Low Income Scheme, information about which is available at the following link: https://www.nhsbsa.nhs.uk/nhs-low-income-scheme.\n\nFurther information on the help available can be found at the following link: https://www.nhs.uk/nhs-services/dentists/get-help-with-dental-costs/.\n\nIn addition, in the 10 Year Health Plan, the Government committed to providing more readily accessible, good quality care to those most in need. In line with this, we are working to transform NHS dentistry so it provides high quality care at the right time, and so nobody goes without because they cannot afford it.\n\nDepartment of Health and Social Care","created_at":"2026-03-05T11:08:00.993Z","updated_at":"2026-03-05T11:08:00.993Z"},"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":700292,"links":{"self":"https://petition.parliament.uk/petitions/700292.json"},"attributes":{"action":"Fund more CAR T Cell Therapy for eligible patients","background":"CAR T Cell therapy is currently allowed for some cancer patients on the NHS when other options have been unsuccessful. I think that people who are eligible should be offered it as a second line of treatment.","additional_details":"I was diagnosed with Primary Mediastianal Non Hodgkin Lymphoma in pregnancy when I was 23 years old. I had a cancer that was 90% curable with first line treatment (chemo & radio) after brutal failed treatments for 2 years, I was finally eligible for Car T Cell therapy, which was so much easier on my body and got me into remission in 90 days. I believe if you fail chemotherapy & radiotherapy and are eligible for CAR-T, you should be allowed it next. Not put on trials and more toxic drugs.\r\n","committee_note":"","state":"closed","signature_count":11234,"created_at":"2024-11-01T13:27:58.910Z","updated_at":"2026-02-17T16:23:36.690Z","rejected_at":null,"opened_at":"2024-11-28T14:46:52.541Z","closed_at":"2025-05-28T22:59:59.999Z","moderation_threshold_reached_at":"2024-11-01T13:48:00.000Z","response_threshold_reached_at":"2025-03-11T21:38:40.000Z","government_response_at":"2025-03-24T11:46:18.365Z","debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":{"responded_on":"2025-03-24","summary":"The National Institute for Health and Care Excellence (NICE) has recommended CAR-T therapies for patients with lymphoma, which are now available to NHS patients in line with NICE’s recommendations.","details":"Improving access to all types of cancer treatment is a key priority for this Government. We published the England Rare Diseases Action Plan 2025 in February 2025, with actions to enable improved and more efficient care for people with rare conditions, support rare disease clinical research trials, and to prepare the NHS to deliver groundbreaking, personalised therapies. \n\nThe UK is a global leader in the development of advanced therapies, with a strong academic and life science industry, and was the first national health system in Europe to commission chimeric antigen receptor T-cell (CAR-T cell) therapy for blood cancer patients. \n\nIn April 2023, the NHS announced the roll out of personalised CAR-T therapies, offering three different CAR-T therapies for six different indications, benefitting adults and children with a range of cancers, with one of the CAR-T drugs available after just one therapy, providing quicker access for patients. \n\nNHS England has been working with stakeholders and the life sciences companies to get centres up and running to deliver CAR-T cell therapy. Three centres have been set up for paediatric patients in London, Manchester and Newcastle, and there are 20 centres set up across England that will be able to provide CAR-T for young people up to the age of 25 years old, and adults. \n\nCAR-T therapy is specifically developed for each individual patient and involves reprogramming the patient’s own immune system cells. These cells are then re-introduced to the patient to target their cancer. It is important to understand CAR-T cell therapy is a highly complex and potentially risky treatment, but it has been shown in trials to cure some patients, even those with quite advanced cancers and where other available treatments have failed.\n\nWe are pleased to learn that you were eligible for CAR-T cell therapy and are now in remission after successful treatment. However, I recognise the difficult journey you went through with failed treatments before receiving your treatment. The decision on which patients are eligible is decided by a national panel of expert clinicians following a referral from a specialist doctor, and in your case this process was followed that verified your eligibility as per recommendation. \n\nTo understand better why some therapies fail, a new research programme was launched last year, involving scientists from London and funded by £9 million from the Medical Research Council and the Office for Life Sciences, and £12.9 million from industry partners. The programme will involve thousands of patients treated with immunotherapy, which CAR-T is a form of, from across the UK and is aiming to discover why at least half of all patients fail to respond to immunotherapy, suffer side effects and to evaluate the barriers to the success of immunotherapy.\n\nIn the UK, medicines need to have a licence before they can be marketed, granted by the Medicines and Healthcare products Regulatory Agency. To get a licence, the manufacturer of the medicine has to provide evidence which shows that the medicine is safe and effective enough to be used for a specific condition and for a specific group of patients, and that they can manufacture the medicine to the required quality.\n\nOnce licensed, new medicines can then be appraised by the National Institute for Health and Care Excellence (NICE). NICE is the body responsible for developing independent, evidence-based guidance for the NHS on whether medicines should be routinely funded based on an assessment of their costs and benefits. NICE only makes recommendations on medicines within their remit and NHS England is required to fund NICE-recommended medicines. \n\nThe Cancer Drugs Fund provides early access for NHS patients to effective cancer drugs recommended by NICE. Further evidence is then collected on the drug through the Cancer Drugs Fund for a defined period of time. This helps NICE decide whether the drug can be recommended for routine NHS funding.  \n\nNICE has evaluated and recommended several CAR-T therapies for use within the Cancer Drugs Fund for the treatment of various cancers, including for large B-cell lymphoma, B-cell acute lymphoblastic leukaemia and mantle cell lymphoma, which are now available to NHS patients in line with NICE’s recommendations. \n\nThe Government is committed to improving diagnosis and treatment for all cancer patients. That’s why we will develop our new National Cancer Plan, which will include further details on how we will improve treatment and outcomes for cancer patients. We encourage you to engage with our call for evidence, where we’re seeking views from individuals, professionals and organisations to inform the development of the plan. This call for evidence closes at 11:59pm on 29 April 2025.\n\nDepartment of Health and Social Care","created_at":"2025-03-24T11:46:18.362Z","updated_at":"2025-03-24T11:46:18.362Z"},"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":701780,"links":{"self":"https://petition.parliament.uk/petitions/701780.json"},"attributes":{"action":"Create a fast-track system for benefit claims for cancer patients","background":"We believe the benefits application system for cancer patients is not fit for purpose. We think it is over-complicated, upsetting, and adds high levels of stress. We would like the Government to create a fast-track system for all of those cancer patients who are seeking benefits.","additional_details":"We think the system should be simplified, streamlined and cost-effective in a way that would benefit patients, medical professionals and the DWP. We believe that cancer patients should be focusing on getting through their treatment and not worrying about paying bills, mortgages or going back to work too soon as time taken for even an initial decision can be months.","committee_note":"","state":"closed","signature_count":5124,"created_at":"2024-11-14T15:35:13.722Z","updated_at":"2025-06-20T23:00:00.895Z","rejected_at":null,"opened_at":"2024-12-20T10:31:59.208Z","closed_at":"2025-06-20T22:59:59.999Z","moderation_threshold_reached_at":"2024-11-14T20:10:30.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DWP","name":"Department for Work and Pensions","url":"https://www.gov.uk/government/organisations/department-for-work-pensions"}],"topics":[]}},{"type":"petition","id":715520,"links":{"self":"https://petition.parliament.uk/petitions/715520.json"},"attributes":{"action":"Allocate annual funding to accelerate breakthroughs in MND research ","background":"We want the Government to allocate annual regular funding for the purpose of research, clinical trials, all stages of trials, in order to prolong the lives of MND patients in a meaningful way. We want innovative research to be prioritised. MND is life limiting still.","additional_details":"Type 1 diabetes was a death sentence until 1923. Cancer was a death sentence 50 years ago, now many patients get active treatment, and it may no longer be life-limiting if caught early. HIV was a death sentence until 1996. Now, it isn't a life-limiting condition, if given proper treatment. We think that increased regular funding would help to prolong the lives of MND patients in a meaningful way. We think funds, research, and money is needed.","committee_note":"","state":"closed","signature_count":4848,"created_at":"2025-01-25T11:53:54.728Z","updated_at":"2025-09-25T23:00:03.298Z","rejected_at":null,"opened_at":"2025-03-25T14:30:09.153Z","closed_at":"2025-09-25T22:59:59.999Z","moderation_threshold_reached_at":"2025-01-25T13:01:00.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":700062,"links":{"self":"https://petition.parliament.uk/petitions/700062.json"},"attributes":{"action":"Fund Breast Cancer Screening from Age 40 & Alternative Screening Options","background":"We urge the Government to fund breast cancer screening at 40+, as thousands under 50 are diagnosed yearly. Early screening can save lives and lessen the need for aggressive treatments. Invest in alternative screening, including options for dense breast tissue, to help ensure no one is overlooked.","additional_details":"Screening from 40 could save lives through earlier detection. The U.S. and Australia have earlier screening. Additionally, we call on the Government to promote, encourage, and support the million women who missed their screening invitations in 2021/22, remind newly eligible patients turning 50, re-engage those who have ignored past invites, and promote regular self-checks for early detection in mainstream media. ","committee_note":"","state":"closed","signature_count":4802,"created_at":"2024-10-30T18:25:37.333Z","updated_at":"2025-05-11T23:00:01.490Z","rejected_at":null,"opened_at":"2024-11-11T13:57:18.138Z","closed_at":"2025-05-11T22:59:59.999Z","moderation_threshold_reached_at":"2024-10-30T18:45:40.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":702277,"links":{"self":"https://petition.parliament.uk/petitions/702277.json"},"attributes":{"action":"Provide funding to support Breast & Cervical Cancer Screening for Disabled Women","background":"We want the government to increase funding to ensure every facility is properly equipped to provide equal care. All women, regardless of disability, should be able to access cancer screenings without fear of exclusion, humiliation, or inadequate care.","additional_details":"Women with disabilities, particularly wheelchair users, can face significant barriers in accessing breast screening and smear tests due to a lack of accessible equipment in many medical facilities across the UK. I believe this violates the Equality Act 2010 and perpetuates health inequalities. A 2021 study found that 63% of disabled women had difficulty accessing routine screenings and another study showed almost two thirds of women with a physical disability had not been able to attend smear tests.","committee_note":"","state":"closed","signature_count":3294,"created_at":"2024-11-20T09:12:53.434Z","updated_at":"2026-02-17T16:23:36.717Z","rejected_at":null,"opened_at":"2025-01-20T11:50:08.990Z","closed_at":"2025-07-20T22:59:59.999Z","moderation_threshold_reached_at":"2024-11-20T09:35:50.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":703953,"links":{"self":"https://petition.parliament.uk/petitions/703953.json"},"attributes":{"action":"Fund post-surgery bras/breast protheses voucher scheme for all women post cancer","background":"I would like the Government to fund a voucher scheme for all women for post surgery bras and breast prosthesis, giving ladies a choice. This would expand the current scheme to enable all women to access support, regardless of their age or income.","additional_details":"We think supporting this scheme would enable ladies to have more choice. The bra and prosthesis voucher could then be presented to a professional bra fitter from an approved list of trained fitters capable of providing that expertise in a less clinical environment than in hospital. We think people who have had breast surgery should be able to access suitable post surgery bras and prosthesis in a variety of different shapes and sizes from a vast selection of brands.","committee_note":"","state":"closed","signature_count":3072,"created_at":"2024-11-25T14:40:02.787Z","updated_at":"2025-07-03T23:00:06.758Z","rejected_at":null,"opened_at":"2025-01-03T15:51:15.981Z","closed_at":"2025-07-03T22:59:59.999Z","moderation_threshold_reached_at":"2024-11-26T07:21:20.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":713180,"links":{"self":"https://petition.parliament.uk/petitions/713180.json"},"attributes":{"action":"Fund access to Holistic Needs Assessment for all NHS cancer patients & follow-up","background":"As a 45-year-old battling cancer, I know it is the toughest ordeal many will face. It's as much a mental battle as it is physical. We believe the NHS should ensure mental health support. So we're calling for funding for Holistic Needs Assessments for all NHS cancer patients.","additional_details":"We think this would treat cancer patients as people, not just bodies that respond to treatment. We think all cancer patients should be given an assessment when they are first diagnosed and solutions should be put in place to solve problems relating to attendant mental health issues. We think medical teams should monitor mental health at every appointment by asking questions so they can act and refer them to appropriate support.","committee_note":"","state":"closed","signature_count":2606,"created_at":"2025-01-08T13:40:53.467Z","updated_at":"2026-02-17T16:23:36.745Z","rejected_at":null,"opened_at":"2025-03-03T15:51:31.488Z","closed_at":"2025-09-03T22:59:59.999Z","moderation_threshold_reached_at":"2025-01-08T13:55:00.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":743042,"links":{"self":"https://petition.parliament.uk/petitions/743042.json"},"attributes":{"action":"Increase funding for NHS cancer care to make patients access treatments quicker","background":"The government should provide more funding to ensure faster cancer diagnosis and treatment by reducing waiting times for biopsies, scans and chemotherapy. Guarantee patients timely access to life-saving care through increased investment, staffing and resources, so delays do not cost lives.","additional_details":"Reform cancer care to ensure faster access to diagnosis and treatment by providing increased funding. Quicker referrals from GP's when there are concerns. Waiting times for biopsies, scans and chemotherapy must be reduced through greater investment, improved capacity and workforce support. And better end of life care, with collaboration from local contracts, pharmacies and GP's, even in rural areas. Patients deserve timely and effective care that meets urgent clinical need.","committee_note":"","state":"closed","signature_count":2154,"created_at":"2025-09-24T19:00:35.357Z","updated_at":"2026-04-22T23:00:00.308Z","rejected_at":null,"opened_at":"2025-10-22T14:36:07.158Z","closed_at":"2026-04-22T22:59:59.999Z","moderation_threshold_reached_at":"2025-09-29T07:58:20.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":729564,"links":{"self":"https://petition.parliament.uk/petitions/729564.json"},"attributes":{"action":"Fund full clinical trials naltrexone to treat cancer","background":"Some studies have shown naltrexone may inhibit cancer. There have never been full clinical trials to investigate this. I would like the government to fund full trials in order to get this drug licensed.","additional_details":"I have stage 4 liver cancer and have been told I don't have more than 2 or 3 years to live. I believe this could give me a longer life if it proves effective.","committee_note":"","state":"closed","signature_count":1689,"created_at":"2025-06-05T23:46:12.516Z","updated_at":"2026-01-04T00:00:16.591Z","rejected_at":null,"opened_at":"2025-07-03T15:11:28.009Z","closed_at":"2026-01-03T23:59:59.999Z","moderation_threshold_reached_at":"2025-06-07T09:08:50.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":720626,"links":{"self":"https://petition.parliament.uk/petitions/720626.json"},"attributes":{"action":"Lower the age for invites to regular mammograms to 40.","background":"Currently the age for routine mammograms to start is 50. I believe this should be lowered to 40.","additional_details":"I was recently diagnosed with breast cancer at age 41. I have no close family history of any cancer including breast or ovarian cancer. I was lucky to find my lump early and my outlook currently is positive. \r\n \r\nDuring my journey it has become apparent that more young people are being diagnosed with breast cancer. I think it's essential that people are aware of their bodies and have the opportunity to catch this as early as possible. I think this would help save lives.\r\n","committee_note":"","state":"closed","signature_count":1574,"created_at":"2025-03-01T23:27:25.906Z","updated_at":"2025-10-11T23:00:03.590Z","rejected_at":null,"opened_at":"2025-04-11T10:06:20.297Z","closed_at":"2025-10-11T22:59:59.999Z","moderation_threshold_reached_at":"2025-03-02T10:29:00.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":737143,"links":{"self":"https://petition.parliament.uk/petitions/737143.json"},"attributes":{"action":"Increase funding for rare cancer research & treatment","background":"I was diagnosed with a rare cancer in 2022, since then I have met other patients in the same situation.","additional_details":"With no body of evidence to support the development of treatments via NICE the NHS may not fund treatment that has been proven to work for other cancers so we may have to crowd fund, apply to charity, wait for clinical trials or beg to access life saving intervention.\r\n \r\nAlongside this we feel staff knowledge is scarce and poor creating high anxiety and sparse access to any help. This must stop.","committee_note":"","state":"closed","signature_count":1218,"created_at":"2025-08-11T19:46:12.708Z","updated_at":"2026-03-06T00:00:18.786Z","rejected_at":null,"opened_at":"2025-09-05T15:46:03.696Z","closed_at":"2026-03-05T23:59:59.999Z","moderation_threshold_reached_at":"2025-08-11T20:34:20.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":729981,"links":{"self":"https://petition.parliament.uk/petitions/729981.json"},"attributes":{"action":"Review the NHS decision to make smear testing every 5 years if HPV negative ","background":"The NHS are changing the smear tests for women aged 25-49 from every three years to every five years if they are HPV negative. We think this should be reviewed. Some women get cervical cancer without having HPV. We think women are going to suffer as a result of this change.","additional_details":"Review the changes they are wishing to make. We think this could lead to some women’s cancer diagnosis being missed. There are women out there that are not HPV positive that have pre-cancerous and cancerous cells. ALOT can happen in five years & we think this policy is diabolical.","committee_note":"","state":"closed","signature_count":1150,"created_at":"2025-06-10T18:24:10.134Z","updated_at":"2026-01-03T00:00:16.448Z","rejected_at":null,"opened_at":"2025-07-02T08:15:53.690Z","closed_at":"2026-01-02T23:59:59.999Z","moderation_threshold_reached_at":"2025-06-10T18:32:50.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":722253,"links":{"self":"https://petition.parliament.uk/petitions/722253.json"},"attributes":{"action":"Fund access to abiraterone in England for high-risk prostate cancer patients","background":"Abiraterone has been available in Scotland and Wales for two years for high-risk patients whose cancer has not yet spread but not in England and Northern Ireland. I want the government fund abiraterone for men in England, giving them the treatment they deserve and has been proven to work.","additional_details":"I think it is unfair that men are not receiving the treatment.\r\nResearch has shown that for these earlier stage patients, the survival rate after six years is improved and that the drug halved the rate of progression of the cancer.\r\n","committee_note":"","state":"closed","signature_count":1032,"created_at":"2025-03-14T18:12:27.730Z","updated_at":"2025-10-17T23:00:08.020Z","rejected_at":null,"opened_at":"2025-04-17T10:37:07.301Z","closed_at":"2025-10-17T22:59:59.999Z","moderation_threshold_reached_at":"2025-03-14T18:41:20.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":717866,"links":{"self":"https://petition.parliament.uk/petitions/717866.json"},"attributes":{"action":"Ban air fresheners & scented products in public spaces","background":"We want the Government to ban air fresheners, scented candles, and fragranced products in public buildings and enclosed public spaces. Scientific evidence shows these products can contribute to indoor air pollution and pose health risks to the public.","additional_details":"Many fragranced products, including air fresheners and scented candles, routinely release volatile organic compounds (VOCs) that have been linked to headaches, gastrointestinal problems, breathing difficulties, and worsening of asthma and allergies. Researchers have also raised concerns that certain chemicals in these products may impact reproductive health and have identified links to cancer.","committee_note":"","state":"closed","signature_count":953,"created_at":"2025-02-13T22:25:51.495Z","updated_at":"2026-01-05T00:00:02.388Z","rejected_at":null,"opened_at":"2025-07-04T10:28:54.569Z","closed_at":"2026-01-04T23:59:59.999Z","moderation_threshold_reached_at":"2025-02-24T11:06:40.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"BT","name":"Department for Business and Trade","url":"https://www.gov.uk/government/organisations/department-for-business-and-trade"}],"topics":[]}},{"type":"petition","id":702104,"links":{"self":"https://petition.parliament.uk/petitions/702104.json"},"attributes":{"action":"Expand the winter fuel allowance to other vulnerable people.","background":"Instead of means testing the winter fuel payment for pensioners, we think all over 60s, those with cancer or long term sick patients should be entitled to £100 per month for each of gas and electricity from Oct to Jan paid directly to the energy company, or £200 per month for all electric homes.","additional_details":"We believe this could help cut hospital admissions and the associated cost to the NHS.","committee_note":"","state":"closed","signature_count":896,"created_at":"2024-11-18T01:15:41.271Z","updated_at":"2025-06-30T23:00:00.843Z","rejected_at":null,"opened_at":"2024-12-30T10:12:07.706Z","closed_at":"2025-06-30T22:59:59.999Z","moderation_threshold_reached_at":"2024-11-18T20:10:00.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"HMT","name":"HM Treasury","url":"https://www.gov.uk/government/organisations/hm-treasury"}],"topics":[]}},{"type":"petition","id":703901,"links":{"self":"https://petition.parliament.uk/petitions/703901.json"},"attributes":{"action":"Fund access to GLP-1 medications through the NHS for women with PCOS","background":"Studies highlight the effectiveness of GLP-1 medications for women with PCOS. We think funding access to GLP-1 treatments, without restrictive BMI criteria or tier system barriers, would improve care and outcomes for these patients.","additional_details":"Studies reveal that women with PCOS have higher absenteeism, increased unemployment, and a greater risk of disability retirement by age 52.\r\n\r\nWithout effective preventive treatments like GLP-1, we think there is a greater burden on the NHS due to downstream complications of untreated PCOS later on. This can include diabetes, cardiovascular disease, infertility, mental health issues, and cancer.\r\n\r\nWe think early intervention is essential to reduce these long-term healthcare costs on the NHS.\r\n","committee_note":"","state":"closed","signature_count":840,"created_at":"2024-11-25T13:39:30.352Z","updated_at":"2025-07-14T23:00:03.881Z","rejected_at":null,"opened_at":"2025-01-14T10:15:59.194Z","closed_at":"2025-07-14T22:59:59.999Z","moderation_threshold_reached_at":"2024-11-25T20:10:50.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":747103,"links":{"self":"https://petition.parliament.uk/petitions/747103.json"},"attributes":{"action":"Review NHS policy on masks, safe air & ventilation to protect vulnerable ","background":"Vulnerable people — those with cancer, immune compromise, or chronic illness — should feel safe in NHS settings, not fearful. We’re calling for a 'do no harm' standard: an automatic right to treatment by FFP2/3 masked staff, safe air and ventilation in every setting and stronger infection control.","additional_details":"The NHS was founded on the duty to 'do no harm'. That means protecting patients from preventable illness, not asking them to plead for it. We ask the Government and NHS England to adopt a “do no harm” infection-prevention standard by:\u2028\u2028- Guaranteeing an automatic right for clinically vulnerable patients to be treated by staff wearing high-filtration masks (such as FFP2/3).\u2028- Maintaining safe air quality and effective ventilation across all health-care settings.\u2028-Reinstate masking in viral surges","committee_note":"","state":"closed","signature_count":736,"created_at":"2025-10-16T15:56:07.082Z","updated_at":"2026-05-25T23:00:00.321Z","rejected_at":null,"opened_at":"2025-11-25T15:39:09.603Z","closed_at":"2026-05-25T22:59:59.999Z","moderation_threshold_reached_at":"2025-10-16T17:14:30.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":749828,"links":{"self":"https://petition.parliament.uk/petitions/749828.json"},"attributes":{"action":"Make people with cancer and unable to work automatically entitled to PIP","background":"Being unable to work due to having cancer does not give you the automatic right to claim PIP, but why shouldn’t it? We think people in these circumstances should be automatically entitled to PIP. Instead they may face an added stress of having to fight the system as well as fight cancer.","additional_details":"People going through cancer treatment or living after having life changing surgeries from cancer and unable to work because of this should be automatically entitled to claim PIP but they are not! Yet you can go to the doctors, complain of a bad back and then may be eligible for it. We think it’s so wrong.\r\nThe government should ensure those going through cancer treatment are automatically entitled to PIP so they don’t potentially have the added stress of having no income.","committee_note":"","state":"closed","signature_count":726,"created_at":"2025-11-07T11:28:15.790Z","updated_at":"2026-06-09T12:32:20.000Z","rejected_at":null,"opened_at":"2025-12-08T16:29:17.550Z","closed_at":"2026-06-08T22:59:59.999Z","moderation_threshold_reached_at":"2025-11-07T19:32:10.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DWP","name":"Department for Work and Pensions","url":"https://www.gov.uk/government/organisations/department-for-work-pensions"}],"topics":[]}},{"type":"petition","id":736239,"links":{"self":"https://petition.parliament.uk/petitions/736239.json"},"attributes":{"action":"Lower the age for invites to regular mammograms to 30","background":"We think the recommended age for routine mammograms should be lowered from 50 to 30. We believe this change could increase early detection, offer better health outcomes, and save countless lives","additional_details":"We feel that ensuring those under 50 can access the crucial early detection that routine mammograms provide is vital.\r\n \r\nAt the age of 41, I've been diagnosed with breast cancer. Like many others, I never considered cancer a possibility. Even when I discovered a small lump, I thought I might be overreacting. What if I had dismissed it and waited until the age of 50 for a routine mammogram? So many young individuals are being diagnosed with breast cancer today, and it's not uncommon for them to feel dismissed or misdiagnose their symptoms as something less serious. Breast cancer doesn't wait for you to turn 50.\r\n","committee_note":"","state":"closed","signature_count":703,"created_at":"2025-08-05T13:18:45.283Z","updated_at":"2026-03-27T00:00:20.687Z","rejected_at":null,"opened_at":"2025-09-26T09:13:54.201Z","closed_at":"2026-03-26T23:59:59.999Z","moderation_threshold_reached_at":"2025-08-05T13:59:40.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"DHSC","name":"Department of Health and Social Care","url":"https://www.gov.uk/government/organisations/department-of-health-and-social-care"}],"topics":[]}},{"type":"petition","id":748589,"links":{"self":"https://petition.parliament.uk/petitions/748589.json"},"attributes":{"action":"Require sanitary waste bins in all toilets regardless of gender","background":"Change UK law to make it a legal requirement for businesses, public places and all social places with female, MALE and unisex restrooms to provide a safe and hygienic means for the disposal of sanitary waste to prevent environmental harm and maintain public health and hygiene standards.","additional_details":"Following treatments relating to the removal of prostate cancers from men, the side effects can be very catastrophic and debilitating. We believe there is not enough emphasis, knowledge or awareness as to the requirements needed for men coping with their need to use sanitary products and the difficulty of disposal when facilities are not available.","committee_note":"","state":"closed","signature_count":681,"created_at":"2025-10-29T20:58:29.406Z","updated_at":"2026-06-01T23:00:04.772Z","rejected_at":null,"opened_at":"2025-12-01T09:18:21.395Z","closed_at":"2026-06-01T22:59:59.999Z","moderation_threshold_reached_at":"2025-10-30T00:40:40.000Z","response_threshold_reached_at":null,"government_response_at":null,"debate_threshold_reached_at":null,"debate_scheduled_on":null,"scheduled_debate_date":null,"debate_outcome_at":null,"creator_name":null,"rejection":null,"government_response":null,"debate":null,"departments":[{"acronym":"MHCLG","name":"Ministry of Housing, Communities & Local Government","url":"https://www.gov.uk/government/organisations/ministry-of-housing-communities-local-government"}],"topics":[]}}]}